Newsroom

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will publish financial results for the third quarter 2026 and provide a business update on Tuesday, November 3, 2026.About Precision BioSciences, Inc.Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving l...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of Pascal Aeschlimann as Vice President of Asia Pacific, effective November 2, 2026. Mr. Aeschlimann, who led STAAR’s commercial expansion across Asia and the Middle East from 2002 to 2010, returns after more than a decade building and leading...

BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer...

NEW YORK--(BUSINESS WIRE)--Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic trading across asset classes, today reported financial results for the quarter ended September 30, 2026. $584.5 million quarterly revenues, an increase of 14.9% (15.4% on a constant currency basis) compared to prior year period $258.5 million quarterly international revenues, an increase of 22.4% (23.8% on a constant current basis) compared to prior year period $3.2 trillion average daily volume (“ADV”)...

BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Frontier Medicines Corporation (Frontier), a clinical-stage, AI-powered precision medicines company that discovers and develops covalent medicines for previously undruggable and hard-to-drug disease-causing targets, starting with cancer, today announced that the U.S. Food and Drug Administration (FDA) has allowed Frontier to proceed to human clinical trials under an Investigational New Drug (IND) application for FMC-242 for the treatment of...

GREENSBORO, N.C.--(BUSINESS WIRE)--UNIFI, Inc. (NYSE: UFI) (together with its consolidated subsidiaries, “UNIFI”), the makers of REPREVE® and one of the world’s leading innovators in recycled and synthetic yarns, today announced that it has completed the previously disclosed sale of two non-strategic real estate assets in Yadkin County, North Carolina for $60 million in gross proceeds, before fees and expenses.The assets sold include approximately 120 acres of land and 500,000 square feet of war...

NEW YORK--(BUSINESS WIRE)--Blackstone Mortgage Trust, Inc. (NYSE: BXMT) today reported its third-quarter 2026 results. The net loss attributable to Blackstone Mortgage Trust for the quarter was $327 million. Third-quarter EPS, Distributable EPS, Distributable EPS prior to realized gains and losses, and dividends paid per basic share were $(1.95), $0.38, $0.42, and $0.47, respectively. In addition, BXMT declared a dividend of $0.30 per share of class A common stock with respect to the fourth qua...

OSHKOSH, Wis.--(BUSINESS WIRE)--Oshkosh Corporation (NYSE: OSK), a leading innovator of purpose-built vehicles and equipment, today reported 2026 third quarter net income of $138.4 million, or $2.22 per diluted share, compared to net income of $196.2 million, or $3.04 per diluted share, for the third quarter of 2025. Adjusted1 net income was $150.1 million, or $2.41 per diluted share, for the third quarter of 2026 compared to $206.6 million, or $3.20 per diluted share, for the third quarter of...

ORLANDO, Fla.--(BUSINESS WIRE)--Hilton Grand Vacations Inc. (NYSE: HGV) (“HGV” or “the Company”) today reports its third quarter 2026 results. Third Quarter 2026 Results1 Total contract sales were $807 million, a decrease of 11.0% compared to the third quarter of 2025. Total revenues were $1.961 billion. Total revenues were affected by a net construction recognition of $536 million. Net income attributable to stockholders was $291 million and diluted EPS was $3.70. Adjusted net income attributa...

SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--TPG Inc. (NASDAQ: TPG), a leading global alternative asset management firm, today reported its unaudited results for the third quarter ended September 30, 2026. A detailed presentation is available through the Investor Relations section of TPG’s website at shareholders.tpg.com. “TPG delivered an exceptional third quarter, reflecting broad-based momentum across the firm and continued progress across each of our strategic objectives,” said Jon W...